Calstabin deficiency, ryanodine receptors, and sudden cardiac death

被引:66
作者
Lehnart, SE
Wehrens, XHT
Marks, AR
机构
[1] Columbia Univ Coll Phys & Surg, Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.bbrc.2004.08.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered cardiac ryanodine receptor (RyR2) function has an important role in heart failure and genetic forms of arrhythmias. RyR2 constitutes the major intracellular Ca2+ release channel in the cardiac sarcoplasmic reticulum (SR). The peptidyl-prolyl isomerase calstabin2 (FKBP12.6) is a component of the RyR2 macromolecular signaling complex. Calstabin2 binding to RyR2 is regulated by PKA phosphorylation of Ser(2809) in RyR2. PKA phosphorylation of RyR2 decreases the binding affinity for calstabin2 and increases RyR2 open probability and sensitivity to Ca2+-dependent activation. In heart failure, a majority of studies have found that RyR2 becomes chronically PKA hyper-phosphorylated which depletes calstabin2 from the channel complex. Calstabin2 dissociation causes a diastolic SR Ca2+ leak contributing to depressed intracellular Ca2+ cycling and decreased cardiac contractility. Missense mutations linked to genetic forms of exercise-induced arrhythmias and sudden cardiac death also cause decreased calstabin2-binding affinity and leaky RyR2 channels. We review the importance of calstabin2 for RyR2 function and excitation-contraction coupling, and discuss new observations that implicate dysregulation of calstabin2 binding as a central mechanism for abnormal calcium cycling in heart failure and triggered arrhythmias. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1267 / 1279
页数:13
相关论文
共 184 条
[121]   REENTRANT AND FOCAL MECHANISMS UNDERLYING VENTRICULAR-TACHYCARDIA IN THE HUMAN HEART [J].
POGWIZD, SM ;
HOYT, RH ;
SAFFITZ, JE ;
CORR, PB ;
COX, JL ;
CAIN, ME .
CIRCULATION, 1992, 86 (06) :1872-1887
[122]   REENTRANT AND NONREENTRANT MECHANISMS CONTRIBUTE TO ARRHYTHMOGENESIS DURING EARLY MYOCARDIAL-ISCHEMIA - RESULTS USING 3-DIMENSIONAL MAPPING [J].
POGWIZD, SM ;
CORR, PB .
CIRCULATION RESEARCH, 1987, 61 (03) :352-371
[123]  
PORTER MC, 1999, J BIOL CHEM, V274, P36831
[124]   Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia [J].
Postma, AV ;
Denjoy, I ;
Hoorntje, TM ;
Lupoglazoff, JM ;
Da Costa, A ;
Sebillon, P ;
Mannens, MMAM ;
Wilde, AAM ;
Guicheney, P .
CIRCULATION RESEARCH, 2002, 91 (08) :E21-E26
[125]  
Prestle J, 2001, CIRC RES, V88, P188
[126]   Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia [J].
Priori, SG ;
Napolitano, C ;
Memmi, M ;
Colombi, B ;
Drago, F ;
Gasparini, M ;
DeSimone, L ;
Coltorti, F ;
Bloise, R ;
Keegan, R ;
Cruz, FES ;
Vignati, G ;
Benatar, A ;
DeLogu, A .
CIRCULATION, 2002, 106 (01) :69-74
[127]  
Priori SG, 2001, CIRCULATION, V103, P196
[128]   β-Adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure [J].
Reiken, S ;
Gaburjakova, M ;
Gaburjakova, J ;
He, KL ;
Prieto, A ;
Becker, E ;
Yi, GH ;
Wang, J ;
Burkhoff, D ;
Marks, AR .
CIRCULATION, 2001, 104 (23) :2843-2848
[129]   β-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure [J].
Reiken, S ;
Wehrens, XHT ;
Vest, JA ;
Barbone, A ;
Klotz, S ;
Mancini, D ;
Burkhoff, D ;
Marks, AR .
CIRCULATION, 2003, 107 (19) :2459-2466
[130]   Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts - Role of phosphatases and response to isoproterenol [J].
Reiken, S ;
Gaburjakova, M ;
Guatimosim, S ;
Gomez, AM ;
D'Armiento, J ;
Burkhoff, D ;
Wang, J ;
Vassort, G ;
Lederer, WJ ;
Marks, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :444-453